The European Commission (EC) has approved ustekinumab for the treatment of moderately to severely active Crohn’s disease in paediatric patients weighing at least 40 kg. The decision follows evidence ...

This Monday, Bio-Thera Solutions and Dr. Reddy’s Laboratories SA announced that they had entered into commercialization and licensing agreements for proposed ustekinumab and golimumab ...

As he approaches his 18th signature shoe, there haven’t been many misses when it comes to design—KD has definitely been on point. Most fans of his line would probably say the KD 6s and 7s are ...

Craig Russell receives funding from BBSRC. If you’ve ever tried discussing medicines with friends or family and found yourself stumbling over the pronunciation — or even resorting to snapping ...

The Nike KD 18 "Soft Pearl" has arrived, and while the color is a softer tone, the silhouette is one that presents strength. Due out on May 1, the shoe arrives dressed in cream-toned upper ...

Among the most significant milestones was the launch of ustekinumab biosimilars following the loss of exclusivity for Stelara. This expansion has played a pivotal role in fostering market ...

Johnson & Johnson (J&J) has announced that Stelara (ustekinumab) has been approved by the European Commission (EC) to treat moderately to severely active Crohn’s disease (CD) in paediatric patients.

If you buy something via one of our links, we may earn a commission. The Nike KD Trey 5 X is on sale for $51, a 49% discount from its normal price of $100. These stylish and supportive basketball ...

The bank recorded KD 26.5 million in net profits at a growth rate of 6% compared with the same period of the past year, with Profit Before Tax “PBT” amounting to KD 31.4 million at a growth rate of 22 ...

Wrapping up Q4 earnings, we look at the numbers and key takeaways for the it services & consulting stocks, including Kyndryl (NYSE:KD) and its peers. IT Services & Consulting companies stand to ...

The concerns around the Stelara exclusivity appear overblown. China’s new tariffs just reignited the same market patterns that led to triple- and quadruple-digit wins for Matt Maley. Get the ...

KUWAIT CITY, Apr 22: Chairman of Kuwait Finance House (KFH) Hamad Abdulmohsen Al Marzouq ‎announced that KFH achieved a net profit of KD 168.1 million for the first ‎quarter of 2025 for shareholders, ...